Nanoparticle delivery of aurora kinase inhibitor may improve tumor treatment [PreClinical]
1. Nanoparticle delivery of the aurora kinase inhibitor AZD2811 led to sustained drug retention in a rat model of colon...
Prior to pursuing her Ph.D. in Biomedical Engineering at Boston University, Christine received her undergraduate degree from Cornell University. Her current research focuses on developing new models of angiogenesis and cancer metastasis. In her free time, Christine enjoys cooking, biking, and exploring different neighborhoods in the Boston area.
1. Nanoparticle delivery of the aurora kinase inhibitor AZD2811 led to sustained drug retention in a rat model of colon...
1. In a mouse model of Alzheimer’s disease (AD), blocking the programmed death-1 (PD-1) pathway with anti-PD-1 antibody treatment...
1. Diacylglyerol kinase α (DGKα) inhibitors R59949 and R59022 partially restored restimulation-induced cell death (RICD) in activated T cells from...
1. The compound ICG-001 sensitized chemoresistant leukemia-initiating cells (LICs) to Imatinib (IM) and inhibited their ability to survive and...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.